Read More
Osteoporosis drug increases bone mineral density in the hip and lumbar spine
New research presented at ACR Convergence, the American College Rheumatology's annual meeting, reveals that romosozumab, an osteoporosis drug, produces substantial gains in bone mineral density in the hip and lumbar spine within one year, and that transitioning patients to a potent antiresorptive drug can lead to even more bone density gains.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
Read More
- Orphanhood decreases with the availability of antiretroviral therapy and male circumcision
- Black men with prostate cancer may have improved response to radiation therapy than white men
- Study hints subtle differences in the quality of immune response based on COVID-19 severity
- Researchers discover how the sponginess of stem cell nuclei controls cell differentiation
Subscribe to:
Post Comments (Atom)
0 Response to "Osteoporosis drug increases bone mineral density in the hip and lumbar spine"
Post a Comment